Global Health Limited (AU:GLH)
ASX:GLH
Want to see AU:GLH full AI Analyst Report?
GLH Stock Chart & Stats
AU$0.09
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.09
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.05 - AU$0.14
Previous CloseN/A
Volume20.61K
Average Volume (3M)18.95K
Market Cap
AU$3.59M
Enterprise ValueAU$334.00B
Total Cash (Recent Filing)AU$1.04M
Total Debt (Recent Filing)AU$1.63M
Price to Earnings (P/E)―
Beta-0.10
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding58,794,537
10 Day Avg. Volume15,411
30 Day Avg. Volume18,951
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)-1.06
Price to Sales (P/S)0.46
P/FCF Ratio-5.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth TrendSustained revenue growth over several years shows underlying demand for GLH's SaaS, licensing and services. A rising revenue base supports scale, recurring subscription economics and long-term customer relationships, improving prospects for margin levelling and product adoption.
Gross Margin RecoveryA return to positive, materially higher gross margins signals improved unit economics and better pricing or cost control on core products. Durable gross margin expansion provides operating leverage as revenue grows, aiding the path to sustainable profitability if SG&A is managed.
Improving Cash BurnA sharply reduced cash burn demonstrates improving operational efficiency and tighter cost discipline. This trend lengthens runway, lowers near-term refinancing needs, and increases the chance management can convert revenue momentum into sustained positive operating cash flow over the medium term.
Bears Say
Negative Shareholders' EquityPersistently negative equity is a structural balance-sheet weakness that raises insolvency and refinancing risk. It limits access to debt and equity markets, constrains strategic flexibility and could force dilutive recapitalisations or covenant pressures that hamper long-term growth initiatives.
Persistent Negative Cash FlowContinued negative operating and free cash flow means the business must rely on external financing or asset sales to fund operations. Over months this restricts reinvestment in product development and sales, increases refinancing risk, and can erode bargaining power with partners and customers.
Ongoing Net LossesSustained operating and net losses indicate the company has not yet achieved durable profitability despite revenue and margin improvements. Continued losses can deplete resources, impede competitive investment, and prolong dependence on financing, making strategic execution more challenging.
Global Health Limited News
GLH FAQ
What was Global Health Limited’s price range in the past 12 months?
Global Health Limited lowest share price was AU$0.05 and its highest was AU$0.14 in the past 12 months.
What is Global Health Limited’s market cap?
Global Health Limited’s market cap is AU$3.59M.
When is Global Health Limited’s upcoming earnings report date?
Global Health Limited’s upcoming earnings report date is Sep 02, 2026 which is in 103 days.
How were Global Health Limited’s earnings last quarter?
Global Health Limited released its earnings results on Feb 25, 2026. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
Is Global Health Limited overvalued?
According to Wall Street analysts Global Health Limited’s price is currently Overvalued.
Does Global Health Limited pay dividends?
Global Health Limited pays a Quarterly dividend of AU$0.01 which represents an annual dividend yield of N/A. See more information on Global Health Limited dividends here
What is Global Health Limited’s EPS estimate?
Global Health Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Health Limited have?
Global Health Limited has 58,794,537 shares outstanding.
What happened to Global Health Limited’s price movement after its last earnings report?
Global Health Limited reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Global Health Limited?
Currently, no hedge funds are holding shares in AU:GLH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Global Health Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-37.50%
12-Months-Change
Fundamentals
Return on Equity
15.41%
Trailing 12-Months
Asset Growth
-1.19%
Trailing 12-Months
Company Description
Global Health Limited
Global Health Limited provides digital health solutions for the healthcare sector in Australia. It provides mental health software for psychologists and psychiatrists; and integrated software solutions for various areas of community health and human services, including drug and alcohol, disability, post-acute care, community care, mental health services, and community rehabilitation, as well as offers software solutions for home care and aged care, consumer engagement tools, general practice, and pharmacy. The company's products include MasterCare EMR, an Electronic Medical Record; MasterCare + that helps organizations in digitizing their services and processes; MasterCare PAS, a patient administration system; PrimaryClinic, a medical and practice management software for general practitioners and specialists that share the same patient demographic. It also provides ReferralNet to send and receive various document types; LifeCard, a personal health record; and HotHealth, a digital engagement tool. In addition, the company offers MasterCare Data Warehouse that removes the need for spreadsheets, exports, and time-consuming analysis; e-switch, a middleware software to exchange data externally, internally, and between different software systems; Patient Portal, an online portal to capture patient data digitally via an online form prior to admission; and Altitude, a cloud hosting service. Global Health Limited was founded in 1985 and is headquartered in Melbourne, Australia.